American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -471 | -252 | -850 | -177 | -264 |
| Depreciation Amortization | 188 | 94 | 367 | 273 | 181 |
| Accounts receivable | -292 | -230 | 163 | -399 | -216 |
| Accounts payable and accrued liabilities | -180 | -28 | 165 | 29 | 243 |
| Other Working Capital | 612 | 413 | 87 | -184 | 126 |
| Other Operating Activity | 474 | 260 | -235 | 324 | -73 |
| Operating Cash Flow | $331 | $257 | $-303 | $-134 | $-3 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25 | -24 | -51 | -48 | -25 |
| Investing Cash Flow | $-25 | $-24 | $-51 | $-48 | $-25 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 143 | 190 | -292 | -304 | -157 |
| Debt Issued | N/A | N/A | 750 | 750 | N/A |
| Debt Repayment | -63 | -32 | -120 | -89 | -59 |
| Other Financing Activity | 0 | 0 | -119 | -120 | 0 |
| Financing Cash Flow | $80 | $158 | $219 | $237 | $-216 |
| Beginning Cash Position | 201 | 201 | 336 | 336 | 336 |
| End Cash Position | 587 | 592 | 201 | 391 | 92 |
| Net Cash Flow | $386 | $391 | $-135 | $55 | $-244 |
| Free Cash Flow | |||||
| Operating Cash Flow | 331 | 257 | -303 | -134 | -3 |
| Capital Expenditure | -25 | -24 | -51 | -48 | -25 |
| Free Cash Flow | 306 | 233 | -354 | -182 | -28 |